BIRC5 and neoplasm: IGF-1, through the activation of key signaling pathways, enhancing the expression of pro-survival factors, such as Bcl2, Bcl-X(L) and Survivin [57], and favoring DNA damage repair [53], is a key target for enhancing the response of tumor cells to drugs.